THERAPY OF ANGINA-PECTORIS WITH LONG-ACTING NITRATES - WHICH AGENT AND WHEN
Citation
J. Abrams, THERAPY OF ANGINA-PECTORIS WITH LONG-ACTING NITRATES - WHICH AGENT AND WHEN, Canadian journal of cardiology, 12, 1996, pp. 9-16
Categorie Soggetti
Cardiac & Cardiovascular System
SICI code
0828-282X(1996)12:<9:TOAWLN>2.0.ZU;2-2
Abstract
Nitroglycerin and the long-acting nitrates are effective antianginal a
gents that have been used in clinical medicine for over 100 years. The
se drugs are reliable, safe, familiar to clinicians, inexpensive, and
easy to use. Side effects are limited to headache and postural hypoten
sive symptoms. Nitrate tolerance or attenuation, - ie, loss of, or dec
rease in, nitrate efficacy with repeated dosing is common and represen
ts the major drawback to chronic therapy. Carefully designed dosing re
gimens and/or appropriate use of nitrate formulations (to include a ni
trate free period each day) will decrease or eliminate the problem of
nitrate tolerance. In head-on comparative studies, nitrates appear to
be as effective as betablockers or calcium channel blockers in the mon
otherapy of chronic angina. Ideal patient characteristics for nitrate
therapy include: predictably favourable response of chest pain to subl
ingual nitroglycerin; angina episodes suggestive of coronary vasoconst
riction or spasm; left ventricular systolic dysfunction; symptoms of c
ongestive heart failure (systolic or diastolic dysfunction).